Interleukin‐18 serum level before and after intralesional immunotherapy with tuberculin purified protein derivative in patients with cutaneous and genital warts-Reference-Cited by-同舟云学术

Interleukin‐18 serum level before and after intralesional immunotherapy with tuberculin purified protein derivative in patients with cutaneous and genital warts

Published:2022-09-20 Issue:12 Volume:21 Page:7035-7042
ISSN:1473-2130
Container-title:Journal of Cosmetic Dermatology
language:en
Short-container-title:J of Cosmetic Dermatology

Author:

Korsa Hadeer Hazem Abo¹^ORCID,Nashaat Hebat‐Allah Hassan²^ORCID,Halim Halim Maher¹^ORCID,Atwa Mona A.¹,Mahmoud Marie Radwa El‐Sayed¹^ORCID

Affiliation:

1. Department of Dermatology, Venereology and Andrology, Faculty of Medicine Suez Canal University Ismailia Egypt

2. Department of Clinical Pathology, Faculty of Medicine Suez Canal University Ismailia Egypt

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jocd.15358

Reference23 articles.

1. Serum level of interleukin‐22 in patients with cutaneous warts: A case‐control study

2. Successful treatment of doughnut warts with intralesional Candida antigen immunotherapy

3. Immunotherapy in cutaneous warts: comparative clinical Study between MMR vaccine, tuberculin, and BCG Vaccine

4. Purified protein derivatives of tuberculin — past, present, and future

5. Intralesional immunotherapy with purified protein derivative (PPD) for cryotherapy‐resistant warts

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effectiveness of different immunotherapies in the treatment of condyloma acuminatum: a network meta-analysis of randomized clinical trials;Frontiers in Medicine;2023-11-21